Monthly Archives: January 2021

Why Did Stifel Nicolaus Downgrade Stitch Fix’s Stock?

Stitch Fix (SFIX – Research Report) received a Hold rating and an $83.00 price target from Stifel Nicolaus analyst Lamont Williams yesterday. The company’s shares closed last Friday at $95.44. Williams has an average return of 175.7% when recommending Stitch

What Made Oppenheimer Downgrade Triterras’ Stock?

Oppenheimer analyst Owen Lau downgraded Triterras (TRIT – Research Report) to Hold yesterday. The company’s shares closed last Friday at $7.30, close to its 52-week low of $6.52. According to TipRanks.com, Lau is a 3-star analyst with an average return

Oppenheimer Issues a Buy Rating on Amgen (AMGN)

Oppenheimer analyst Jay Olson assigned a Buy rating to Amgen (AMGN – Research Report) yesterday and set a price target of $266.00. The company’s shares closed last Friday at $241.43. According to TipRanks.com, Olson is a 3-star analyst with an

Principal Financial (PFG) Receives a Hold from RBC Capital

RBC Capital analyst Mark Dwelle maintained a Hold rating on Principal Financial (PFG – Research Report) on January 29 and set a price target of $52.00. The company’s shares closed last Friday at $49.27. According to TipRanks.com, Dwelle is a

Analysts Offer Insights on Healthcare Companies: Theratechnologies (NASDAQ: THTX) and Dicerna Pharma (NASDAQ: DRNA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Theratechnologies (THTX – Research Report) and Dicerna Pharma (DRNA – Research Report). Theratechnologies (THTX) In a report issued on January 29, Brian Abrahams

Analysts Are Neutral on These Financial Stocks: Arthur J Gallagher & Co (AJG), Federated Hermes (FHI)

Analysts fell to the sidelines weighing in on Arthur J Gallagher & Co (AJG – Research Report), Federated Hermes (FHI – Research Report) and First Financial Bancorp (FFBC – Research Report) with neutral ratings, indicating that the experts are neither